- Vulnerable Plaque & Ischemic Plaque Phenotypes
- Current usage & limitations of CTA for CAD
- Non-invasive plaque characterization from CTA
- ElucidVivo Plaque Analysis Software & Case Reviews
- Utilizing ElucidVivo in clinical practice
- Q&A
Gregg W. Stone, MD Mount Sinai Heart Health System, New York, NY |
Ron Blankstein, MD Brigham and Women’s Hospital, Boston, MA |
Renu Virmani, MD CVPath Institute, Gaithersburg, MD |
U. Joseph Schoepf, MD The Medical University of South Carolina, Charleston, SC |
Tony Das, MD Baylor Heart Hospital, Plano, TX |
This program is supported by: |